News | Health & Safety
24 Nov 2017 22:15
NZCity News
NZCity CalculatorReturn to NZCity

  • Start Page
  • Personalise
  • Sport
  • Weather
  • Olympic Games
  • Finance
  • Shopping
  • Jobs
  • Horoscopes
  • Lotto Results
  • Photo Gallery
  • Site Gallery
  • TVNow
  • Dating
  • SearchNZ
  • NZSearch
  • Crime.co.nz
  • RugbyLeague
  • Make Home
  • About NZCity
  • Contact NZCity
  • Your Privacy
  • Advertising
  • Login
  • Join for Free

  •   Home > News > Health & Safety

    Pacific Edge gets $3m extension to grant

    Pacific Edge has won a two-year extension to its research grant to fund the development of its Cxbladder products for bladder cancer detection.


    Pacific Edge has won a two-year extension to its Callaghan Innovation research grant to fund the development of its Cxbladder diagnostic suite of products for bladder cancer detection.

    The Dunedin-based firm has received up to $3 million of extra funding for research and development spread over two years, on top of an initial three-year grant of $4.5m it received in 2014, it said in a statement.

    Since the first grant was awarded, Pacific Edge has launched three new products to add to the original bladder cancer diagnostics test, with each test addressing different clinical needs.

    The shares rose 3.5 per cent to 59 cents.

    "Investment into research and development is a major focus for Pacific Edge and we are continually looking at how we can provide better and more targeted diagnostic tools for clinicians and their patients," chief executive David Darling said.

    "The Growth Grant supplements Pacific Edge's own investment into R&D and will enable us to bring new innovations through into new products and product improvements."

    The company raised $8 million in February through a share placement to institutional investors to shore up its balance sheet as it ramps up efforts to lift commercial growth.

    It started making commercial sales in 2013 and at the time was targeting $100m in gross revenue within five years.

    The recent capital raise left it with $9m of cash to fund its immediate growth needs, and when reporting its first half result in November it signalled plans to have all four Cxbladder products fully launched in the US by 2018.

    # (BusinessDesk receives funding from Callaghan Innovation to help cover the commercialisation of innovation.)


    NZN




    © 2017 NZN, NZCity


     Other Health & Safety News
     24 Nov: NZ shares mixed; Ryman and Stride gain
     23 Nov: NZ shares fall, led by A2, Kathmandu
     23 Nov: Another lung disease making comeback
     23 Nov: Young smokers need access to quit products
     22 Nov: Decline in 18-24 year olds drinking
     22 Nov: Study supports NZ's chest pain protocol
     22 Nov: Myanmar's discrimination against Rohingya Muslims is 'apartheid': Amnesty International
     Top Stories

    RUGBY RUGBY
    All Blacks fear factor missing: Gatland More...


    BUSINESS BUSINESS
    NZ shares mixed; Ryman and Stride gain More...



     Today's News

    Law and Order:
    Kim Kardashian, Rihanna throw support behind jailed teen Cyntoia Brown 22:07

    Law and Order:
    New charge in HB indecent assault case 21:57

    Entertainment:
    Scott Weiland left behind music and sports memorabilia worth thousands after his death 21:50

    Entertainment:
    Nick Jonas is "in no rush" to start a family 21:20

    Soccer:
    Rested Phoenix primed for Mariners 21:17

    Entertainment:
    Kevin Hart and Eniko Parrish are bringing their son home from the hospital 20:50

    Golf:
    Day makes his move at Australian Open golf 20:27

    Entertainment:
    Nathan Followill and Jesse Baylin are expecting their second child 20:20

    Entertainment:
    Gerard Butler has adopted a stray dog he found "up a mountain in Bulgaria" 19:50

    Entertainment:
    Miley Cyrus has been gifted a rainbow necklace by her fiancé Liam Hemsworth in honour of her 25th birthday 19:20


     News Search






    Power Search


    © 2017 New Zealand City Ltd